JP2016532456A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016532456A5 JP2016532456A5 JP2016543270A JP2016543270A JP2016532456A5 JP 2016532456 A5 JP2016532456 A5 JP 2016532456A5 JP 2016543270 A JP2016543270 A JP 2016543270A JP 2016543270 A JP2016543270 A JP 2016543270A JP 2016532456 A5 JP2016532456 A5 JP 2016532456A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- disease
- composition according
- tmp
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2013903588A AU2013903588A0 (en) | 2013-09-18 | Modified anti-inflammatory proteins and method of use | |
| AU2013903588 | 2013-09-18 | ||
| PCT/AU2014/050240 WO2015039189A1 (en) | 2013-09-18 | 2014-09-18 | Modified anti-inflammatory proteins and method of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016532456A JP2016532456A (ja) | 2016-10-20 |
| JP2016532456A5 true JP2016532456A5 (enExample) | 2017-08-31 |
Family
ID=52688012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016543270A Pending JP2016532456A (ja) | 2013-09-18 | 2014-09-18 | 改変型抗炎症性タンパク質及び使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US10822395B2 (enExample) |
| EP (2) | EP4509188A3 (enExample) |
| JP (1) | JP2016532456A (enExample) |
| CN (1) | CN105745223A (enExample) |
| AU (1) | AU2014324094B2 (enExample) |
| CA (1) | CA2924220A1 (enExample) |
| WO (1) | WO2015039189A1 (enExample) |
| ZA (1) | ZA201602304B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105745223A (zh) * | 2013-09-18 | 2016-07-06 | 詹姆斯库克大学 | 修饰的抗炎蛋白及使用方法 |
| WO2022192955A1 (en) * | 2021-03-17 | 2022-09-22 | James Cook University | Proteins and uses thereof |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1164225B (it) | 1983-05-13 | 1987-04-08 | Anic Spa | Analoghi retro-invertiti del pentapeptide potenziante la bradichina bpp5a e metodi per la loro preparazione |
| US5284760A (en) | 1989-04-03 | 1994-02-08 | Feinstone Stephen M | Techniques for producing site-directed mutagenesis of cloned DNA |
| US6090790A (en) | 1989-12-14 | 2000-07-18 | Eriksson; Elof | Gene delivery by microneedle injection |
| US5220007A (en) | 1990-02-15 | 1993-06-15 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of RNA and production of encoded polypeptides |
| US5149797A (en) | 1990-02-15 | 1992-09-22 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of rna and production of encoded polypeptides |
| US6054122A (en) | 1990-11-27 | 2000-04-25 | The American National Red Cross | Supplemented and unsupplemented tissue sealants, methods of their production and use |
| DE69233035D1 (de) | 1991-12-24 | 2003-06-05 | Harvard College | Gezielte punkt-mutagenese von dna |
| US6756211B1 (en) | 1992-05-11 | 2004-06-29 | Corvas International, Inc. | Neutropohil inhibitors |
| US5389514A (en) | 1992-08-28 | 1995-02-14 | Fox Chase Cancer Center | Method for specifically altering the nucleotide sequence of RNA |
| US6562596B1 (en) | 1993-10-06 | 2003-05-13 | Amgen Inc. | Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods |
| US5962427A (en) | 1994-02-18 | 1999-10-05 | The Regent Of The University Of Michigan | In vivo gene transfer methods for wound healing |
| AUPM672594A0 (en) | 1994-07-08 | 1994-08-04 | Royal Children's Hospital Research Foundation | A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| US5789166A (en) | 1995-12-08 | 1998-08-04 | Stratagene | Circular site-directed mutagenesis |
| WO1999047070A1 (en) | 1998-03-18 | 1999-09-23 | Wake Forest University | Improved implantable biomaterials, compositions and methods for their preparation and uses thereof |
| JP2000007575A (ja) | 1998-06-17 | 2000-01-11 | Fuji Chem Ind Ltd | 抗アレルギー剤 |
| AU2001252278A1 (en) | 2000-04-05 | 2001-10-15 | Ipf Pharmaceuticals Gmbh | Medicament containing a tissue inhibitor of metalloproteinases-2 (timp-2) as an osteo-anabolically active substance |
| JP4426179B2 (ja) | 2000-12-18 | 2010-03-03 | アライバ ファーマシューティカルズ，インコーポレイティド | 多機能性プロテアーゼインヒビターおよびそれらの疾患治療における使用 |
| DE10138550A1 (de) | 2001-08-06 | 2003-02-20 | Wolfgang E Berdel | Verwendung von TIMP-1 als Immunsuppressivum |
| US7303752B2 (en) | 2001-10-17 | 2007-12-04 | The George Washington University | Hookworm vaccine |
| NZ536796A (en) | 2002-04-25 | 2007-03-30 | Scripps Research Inst | Treatment and prevention of pulmonary conditions comprising at least one lung surfactant polypeptide and at least one protease inhibitor, lipase inhibitor or an anti-oxidant |
| US7928132B2 (en) | 2004-08-06 | 2011-04-19 | Ohio University | Methods for the amelioration of episodes of acute or chronic ulcerative colitis |
| WO2007005672A2 (en) | 2005-06-30 | 2007-01-11 | The Scripps Research Institute | Treatment and prevention of respiratory diseases and conditions |
| EP1910417A2 (en) | 2005-07-29 | 2008-04-16 | Imperial Innovations Limited | Compounds |
| WO2010048432A1 (en) | 2008-10-22 | 2010-04-29 | Dyax Corp. | Combination treatments comprising protease binding proteins for inflammatory disorders |
| WO2011119484A1 (en) | 2010-03-23 | 2011-09-29 | Iogenetics, Llc | Bioinformatic processes for determination of peptide binding |
| US9637527B2 (en) * | 2012-03-13 | 2017-05-02 | James Cook University | Method for treating inflammation with an Ac-TMP-2 protein |
| US20140274874A1 (en) | 2013-03-14 | 2014-09-18 | Amgen Inc. | Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methods |
| CN105745223A (zh) | 2013-09-18 | 2016-07-06 | 詹姆斯库克大学 | 修饰的抗炎蛋白及使用方法 |
| AU2014324093A1 (en) * | 2013-09-18 | 2016-04-28 | James Cook University | Anti-inflammatory proteins and methods of use |
-
2014
- 2014-09-18 CN CN201480061261.2A patent/CN105745223A/zh active Pending
- 2014-09-18 CA CA2924220A patent/CA2924220A1/en not_active Abandoned
- 2014-09-18 WO PCT/AU2014/050240 patent/WO2015039189A1/en not_active Ceased
- 2014-09-18 EP EP24208439.0A patent/EP4509188A3/en active Pending
- 2014-09-18 AU AU2014324094A patent/AU2014324094B2/en active Active
- 2014-09-18 EP EP14845452.3A patent/EP3046937A4/en not_active Ceased
- 2014-09-18 JP JP2016543270A patent/JP2016532456A/ja active Pending
- 2014-09-18 US US15/023,165 patent/US10822395B2/en active Active
-
2016
- 2016-04-06 ZA ZA2016/02304A patent/ZA201602304B/en unknown
-
2020
- 2020-10-15 US US17/071,563 patent/US11976108B2/en active Active
-
2024
- 2024-01-16 US US18/414,112 patent/US12466873B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lis et al. | State of the art paper Tumor necrosis factor inhibitors–state of knowledge | |
| Koszalka et al. | Influenza antivirals currently in late‐phase clinical trial | |
| JP2015517489A5 (enExample) | ||
| JP2017079785A5 (enExample) | ||
| JP2013521303A5 (enExample) | ||
| JP2014511844A5 (enExample) | ||
| JP2016522168A5 (enExample) | ||
| JP2019510739A5 (enExample) | ||
| JP2016519650A5 (enExample) | ||
| JP2015007098A5 (enExample) | ||
| JP2015096557A5 (enExample) | ||
| JP2016512248A5 (enExample) | ||
| JP2015057436A5 (enExample) | ||
| Mota et al. | Guidelines for the drug treatment of rheumatoid arthritis | |
| JP2016538885A5 (enExample) | ||
| Vitale et al. | Demographic, clinical and therapeutic findings in a monocentric cohort of adult patients with suspected PFAPA syndrome | |
| JP2011528332A5 (enExample) | ||
| Strychalski et al. | Cytokine modulators in plaque psoriasis–A review of current and prospective biologic therapeutic approaches | |
| JP2014527040A5 (enExample) | ||
| JP2016512817A5 (enExample) | ||
| JP2015511588A5 (enExample) | ||
| JP2016519670A5 (enExample) | ||
| JP2017501999A5 (enExample) | ||
| MX2020006840A (es) | Composicion farmaceutica que comprende un peptido tipo apl. | |
| Markatseli et al. | Survival of TNF-alpha antagonists in rheumatoid arthritis: a long-term study |